首页> 外文OA文献 >Towards a universal vaccine for avian influenza: Protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus
【2h】

Towards a universal vaccine for avian influenza: Protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus

机译:迈向禽流感通用疫苗:经修饰的痘苗病毒安卡拉和腺病毒疫苗在低致病性禽流感病毒攻击的鸡中表达保守流感抗原的保护作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Current vaccines targeting surface proteins can drive antigenic variation resulting either in the emergence of more highly pathogenic viruses or of antigenically distinct viruses that escape control by vaccination and thereby persist in the host population. Influenza vaccines typically target the highly mutable surface proteins and do not provide protection against heterologous challenge. Vaccines which induce immune responses against conserved influenza epitopes may confer protection against heterologous challenge. We report here the results of vaccination with recombinant modified Vaccinia virus Ankara (MVA) and Adenovirus (Ad) expressing a fusion construct of nucleoprotein and matrix protein (NP. +. M1). Prime and boost vaccination regimes were trialled in different ages of chicken and were found to be safe and immunogenic. Interferon-γ (IFN-γ) ELISpot was used to assess the cellular immune response post secondary vaccination. In ovo Ad prime followed by a 4 week post hatch MVA boost was identified as the most immunogenic regime in one outbred and two inbred lines of chicken. Following vaccination, one inbred line (C15I) was challenged with low pathogenic avian influenza (LPAI) H7N7 (A/Turkey/England/1977). Birds receiving a primary vaccination with Ad-NP. +. M1 and a secondary vaccination with MVA-NP. +. M1 exhibited reduced cloacal shedding as measured by plaque assay at 7 days post infection compared with birds vaccinated with recombinant viruses containing irrelevant antigen. This preliminary indication of efficacy demonstrates proof of concept in birds; induction of T cell responses in chickens by viral vectors containing internal influenza antigens may be a productive strategy for the development of vaccines to induce heterologous protection against influenza in poultry. © 2012 Elsevier Ltd.
机译:当前针对表面蛋白的疫苗可以驱动抗原变异,从而导致更高致病性的病毒的出现或抗原不同的病毒的出现,这些病毒可以通过疫苗逃脱控制,从而在宿主种群中持续存在。流感疫苗通常靶向高度易变的表面蛋白,不能针对异源攻击提供保护。诱导针对保守的流感抗原决定簇的免疫反应的疫苗可以赋予针对异源攻击的保护。我们在这里报告了表达重组核蛋白和基质蛋白(NP .. M1)融合构建体的重组修饰的痘苗病毒安卡拉(MVA)和腺病毒(Ad)的疫苗接种结果。已在不同年龄的鸡中试验了初免和加强疫苗接种方案,发现它们是安全且具有免疫原性的。干扰素-γ(IFN-γ)ELISpot用于评估二次疫苗接种后的细胞免疫反应。在卵内,在孵化后4周进行Ad Ad初免,MVA增强被认为是一只自交系和两个自交系鸡中最具免疫原性的方案。接种疫苗后,用低病原性禽流感(LPAI)H7N7攻击一个自交系(C15I)(A / Turkey / England / 1977)。鸟类接受Ad-NP的初次疫苗接种。 +。 M1和MVA-NP的二次疫苗接种。 +。与接种了含有无关抗原的重组病毒的禽类相比,M1感染后7天的斑块测定显示出泄殖腔脱落的减少。该功效的初步指示证明了禽类概念的证明。含有内部流感抗原的病毒载体在鸡中诱导T细胞应答可能是开发疫苗以诱导对禽流感的异源保护的有效策略。 ©2012爱思唯尔有限公司。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号